As a recognized leader in conducting complex, global oncology/hematology trials, PRA has contributed to the approval of 16 important drugs. During the last 5 years, PRA has participated in 295+ oncology and hematology clinical projects globally in every phase and virtually every indication, including supportive care.

Explore related content and topics